Braskem vs Dow
BAK and DOW side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BAK and DOW compare
Dow grew revenue faster over the last twelve months (4.2% versus −8.6% for Braskem).
Dow pays a dividend yielding 4.2%; Braskem does not pay one.
Dow scores higher on the StockData Score (8 against 0 for Braskem), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BAK | DOW |
|---|---|---|
| Size and price | ||
| Market cap | – | $23.9B |
| Share price | $1.13 | $33.04 |
| Change, 1 year | −62.2% | 49.0% |
| Change, 5 years | −93.3% | −42.4% |
| Beta (5Y) | 0.74 | 0.71 |
| Employees | 1,809 | 35K |
| StockData Score | ||
| Total score | 0 | 8 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 0 |
| Health score | 0 | 3 (better) |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/S | – | 0.6× |
| P/B | – | 1.5× |
| EV/EBITDA | – | 12.2× |
| Fair value | – | $37.55 |
| Margin of safety | – | 12.0% |
| Growth | ||
| Revenue growth (TTM) | −8.6% | 4.2% (better) |
| Revenue growth, 5Y average | 3.9% (better) | 0.73% |
| Profitability | ||
| Gross margin | 2.2% | 11.1% (better) |
| Operating margin | −2.6% | – |
| Net margin | −14.0% | – |
| FCF margin | −10.3% | – |
| Return on invested capital | −4.4% | – |
| Financial health | ||
| Debt / equity | – | 1.08 |
| Net debt / EBITDA | 12.16 | 4.19 (better) |
| Interest coverage | −0.3× | – |
| Current ratio | 0.76 | 1.76 (better) |
| Altman Z-score | – | 1.58 |
| Piotroski F-score | 2 | – |
| Dividends and buybacks | ||
| Dividend yield | – | 4.2% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | 0.00% |
| Shareholder yield | – | 4.2% |
| Ownership | ||
| Held by institutions | 4.1% | 77.9% |
| Held by insiders | 3.2% | 0.28% |
| Short interest, % of float | – | 3.8% |
Go deeper
- BAK stock overview
- BAK income statement
- BAK valuation and score
- DOW stock overview
- DOW income statement
- DOW valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.